Skip to main content

Table 3 Comparisons of biochemical parameters and treatment for anemia during the 6-month follow-up

From: Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

 

At inclusion (M0)

At month 3

At month 6

P

Biochemical parameters

 Hemoglobin (g/dL)

11.13 ± 1.05

11.30 ± 1.09

11.00 ± 1.16

0.54

 TSAT (%)

41.47 ± 22.37

29.27 ± 10.88

32.58 ± 13.63

0.01

 Serum ferritin (μg/L)

947.71 ± 1056.42

672.93 ± 490.16

570.73 ± 424.41

0.0001

 Parathyroid hormone (pg/mL)

188.03 ± 154.67

ND

212.73 ± 176.85

0.27

 β2-microglobuline (mg/L)

25.88 ± 7.77

22.96 ± 5.57

21.80 ± 6.53

0.00001

 C-reactive protein (mg/L)

14.59 ± 27.10

9.04 ± 10.14

11.81 ± 30.60

0.64

 Serum albumin (g/L)

35.07 ± 4.52

37.34 ± 2.99

40.02 ± 4.58

0.0002

Treatment

 ESA (μg/28 days)

126.4 ± 91.9

109.63 ± 101.03

108.20 ± 112.70

0.07

 Iron supplementation (mg/week)

77.78 ± 87.62

15.56 ± 42.40

24.44 ± 52.90

0.0003

  1. ESA erythropoiesis-stimulating agent